Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis | Zendy

M. Estée Török | Zendy; N. T. B. Yen | Zendy; Ha Vinh | Zendy; N. T. H. | Zendy; N. H. Phu | Zendy; P. P. | Zendy; Nguyễn Thị Dung | Zendy; Nguyen VV Chau | Zendy; N D Bang | Zendy; Tien Anh Nguyen | Zendy; Nguyen Hien Minh | Zendy; Nguyen Quang Hien | Zendy; P. V. K. Thai | Zendy; Danfeng Dong | Zendy; D. T. T. Anh | Zendy; Nguyen Thi Cam Thoa | Zendy; Nguyễn Ngọc Hải | Zendy; NgocLan Nguyen | Zendy; Nguyễn Thị Ngọc Lan | Zendy; Hoang Thi Quy | Zendy; Nguyen Huy Dung | Zendy; T T Hien | Zendy; N.T. Chinh | Zendy; Cameron P. Simmons | Zendy; Marion de Jong | Zendy; Marcel Wolbers | Zendy; Jeremy Farrar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis

Author(s) -

M. Estée Török,

N. T. B. Yen,

Ha Vinh,

N. T. H.,

N. H. Phu,

P. P.,

Nguyễn Thị Dung,

Nguyen VV Chau,

N D Bang,

Tien Anh Nguyen,

Nguyen Hien Minh,

Nguyen Quang Hien,

P. V. K. Thai,

Danfeng Dong,

D. T. T. Anh,

Nguyen Thi Cam Thoa,

Nguyễn Ngọc Hải,

NgocLan Nguyen,

Nguyễn Thị Ngọc Lan,

Hoang Thi Quy,

Nguyen Huy Dung,

T T Hien,

N.T. Chinh,

Cameron P. Simmons,

Marion de Jong,

Marcel Wolbers,

Jeremy Farrar

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir230

Subject(s) - medicine , efavirenz , tuberculous meningitis , adverse effect , hazard ratio , randomized controlled trial , lamivudine , meningitis , randomization , abacavir , zidovudine , placebo , confidence interval , pediatrics , surgery , antiretroviral therapy , human immunodeficiency virus (hiv) , viral load , immunology , viral disease , virus , alternative medicine , pathology , hepatitis b virus

The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-associated tuberculous meningitis is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research